Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

AVALON PHARMACEUTICALS INC (AVRX)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-08Dec-31-07Dec-31-06Dec-31-05Dec-31-04Dec-31-03Dec-31-02
   10-K10-K10-K10-K10-K10-KS-1/A
Revenues  15.816.116.017.312.612.612.8
            Revenue growth  -2.2%0.9%-7.7%37.8%-0.2%-1.7% 
Cost of goods sold  15.515.313.315.810.712.512.8
Gross profit  0.30.82.71.51.90.10.0
            Gross margin  2.0%5.0%17.0%8.9%15.1%0.8%0.0%
Selling, general and administrative   [+]5.38.27.75.14.34.64.4
EBITDA   [+]-18.8-20.7-15.8-16.7-10.3-14.5 
            EBITDA margin  -119.0%-128.5%-98.7%-96.2%-82.2%-115.3%-134.6%
Depreciation and amortization  1.62.02.42.62.82.4 
EBIT   [+]-20.4-22.8-18.2-19.3-13.1-17.0-17.3
            EBIT margin  -129.4%-141.1%-113.8%-111.4%-104.2%-134.6%-134.6%
Non-recurring items  1.6      
Interest income, net   [+]0.01.00.5-0.6-0.60.01.1
Other income (expense), net  0.10.10.60.70.0-0.10.0
Pre-tax income  -21.8-21.7-17.1-19.3-13.7-17.1-16.2
Income taxes  0.00.00.00.00.00.00.0
            Tax rate  0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income  -21.8-21.7-17.1-19.3-13.7-17.1-16.2
            Net margin  -138.4%-134.4%-106.9%-111.3%-108.6%-135.4%-125.9%
   
Basic EPS   [+]($1.24)($1.42)($1.74)($0.01)($0.11)($0.13)($0.13)
Diluted EPS   [+]($1.24)($1.42)($1.74)($0.01)($0.11)($0.13)($0.13)
   
Shares outstanding (basic)   [+]17.615.39.82,129.4128.4126.6125.8
Shares outstanding (diluted)   [+]17.615.39.82,129.4128.4126.6125.8
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy